Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05470 | 33248065 | Metabolism | Functions of amyloid precursor protein in metabolic diseases. | 2020 | Details |
| A05472 | 33246954 | Sci Adv | CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression. | 2020 | Details |
| A05473 | 33246225 | Biomed Pharmacother | Akkermansia muciniphila: A potential novel mechanism of nuciferine to improve hyperlipidemia. | 2020 | Details |
| A05475 | 33244884 | J Cachexia Sarcopenia Muscle | Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models. | 2020 | Details |
| A05477 | 33244400 | J Nutr Sci | Associations between dietary total antioxidant capacity and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study. | 2020 | Details |
| A05482 | 33239899 | Diabetes Metab Syndr Obes | CHDH-PNPLA3 Gene-Gene Interactions Predict Insulin Resistance in Children with Obesity. | 2020 | Details |
| A05484 | 33238880 | Mol Med | Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding. | 2020 | Details |
| A05489 | 33235221 | Nat Commun | Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A. | 2020 | Details |
| A05495 | 33233601 | Diagnostics (Basel) | Circulating Bile Acids Profiles in Obese Children and Adolescents: A Possible Role of Sex, Puberty and Liver Steatosis. | 2020 | Details |
| A05499 | 33229553 | Proc Natl Acad Sci U S A | Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease. | 2020 | Details |
| A05503 | 33227430 | Clin Gastroenterol Hepatol | Agreement Between the Prevalence of Nonalcoholic Fatty Liver Disease Determined by Transient Elastography and Fatty Liver Indices. | 2020 | Details |
| A05504 | 33227291 | Biochem Pharmacol | Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammation. | 2020 | Details |
| A05505 | 33227217 | J Med Food | Whole Red Raspberry (Rubus idaeus)-Enriched Diet Is Hepatoprotective in the Obese Zucker Rat, a Model of the Metabolic Syndrome. | 2020 | Details |
| A05506 | 33225408 | Obes Surg | Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis. | 2020 | Details |
| A05507 | 33224584 | Am J Cardiovasc Dis | Sex differences in cardiovascular diseases and associated risk factors in non-alcoholic steatohepatitis. | 2020 | Details |
| A05510 | 33222696 | Lipids Health Dis | Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. | 2020 | Details |
| A05511 | 33222473 | Rev Esp Enferm Dig | Overall clinical and economic impact of non-alcoholic fatty liver disease. | 2021 | Details |
| A05514 | 33220492 | Mol Metab | Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. | 2020 | Details |
| A05517 | 33220422 | Pharmacol Res | Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway. | 2020 | Details |
| A05524 | 33219119 | BMJ Open Diabetes Res Care | Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans. | 2020 | Details |
| A05526 | 33218301 | BMC Fam Pract | Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association? | 2020 | Details |
| A05532 | 33217052 | J Gastroenterol Hepatol | A review of non-alcoholic fatty liver disease in non-obese and lean individuals. | 2020 | Details |
| A05537 | 33215434 | Eur Rev Med Pharmacol Sci | Energy-restricted Central-European diet stimulates liver microsomal function in obese postmenopausal women - a randomized nutritional trial with a comparison to energy-restricted Mediterranean diet. | 2020 | Details |
| A05540 | 33214329 | Pediatrics | Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018. | 2020 | Details |
| A05546 | 33212947 | Nutrients | Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05550 | 33210603 | Elife | CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance. | 2020 | Details |
| A05562 | 33205261 | Curr Gastroenterol Rep | Endobariatrics and Metabolic Endoscopy: Can We Solve the Obesity Epidemic with Our Scope? | 2020 | Details |
| A05564 | 33204721 | Biomed Res Int | A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study. | 2020 | Details |
| A05571 | 33203257 | Int J Food Sci Nutr | Hepatoprotective and anti-inflammatory effects of a standardized pomegranate (Punica granatum) fruit extract in high fat diet-induced obese C57BL/6 mice. | 2020 | Details |
| A05576 | 33202693 | Int J Mol Sci | IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05583 | 33200011 | World J Hepatol | Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! | 2020 | Details |
| A05584 | 33199780 | Nat Commun | AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis. | 2020 | Details |
| A05594 | 33195636 | World J Clin Cases | Relationship between non-alcoholic fatty liver disease and coronary heart disease. | 2020 | Details |
| A05602 | 33193730 | Front Genet | Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases. | 2020 | Details |
| A05603 | 33193105 | Front Endocrinol (Lausanne) | Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH. | 2020 | Details |
| A05604 | 33193088 | Front Endocrinol (Lausanne) | Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity. | 2020 | Details |
| A05610 | 33190175 | Obes Surg | Development and Validation of a Predictive Model of Success in Bariatric Surgery. | 2020 | Details |
| A05613 | 33187321 | Pharmaceuticals (Basel) | Germinated Soybean Embryo Extract Ameliorates Fatty Liver Injury in High-Fat Diet-Fed Obese Mice. | 2020 | Details |
| A05617 | 33186794 | Biomed Pharmacother | Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. | 2020 | Details |
| A05621 | 33186123 | Aging (Albany NY) | The nuclear and cytoplasmic roles of miR-320 in non-alcoholic fatty liver disease. | 2020 | Details |
| A05622 | 33185977 | Obesity (Silver Spring) | Can Baseline Characteristics be Used to Predict Liver Disease Outcomes in Pediatric Nonalcoholic Fatty Liver Disease? | 2020 | Details |
| A05623 | 33185911 | Hepatology | Neutral Ceramidase Mediates Nonalcoholic Steatohepatitis by Regulating Monounsaturated Fatty Acids and Gut IgA+ B Cells. | 2021 | Details |
| A05629 | 33182720 | Int J Environ Res Public Health | Resistance Exercise Regulates Hepatic Lipolytic Factors as Effective as Aerobic Exercise in Obese Mice. | 2020 | Details |
| A05630 | 33182700 | Nutrients | Fructose-Induced Intestinal Microbiota Shift Following Two Types of Short-Term High-Fructose Dietary Phases. | 2020 | Details |
| A05633 | 33181119 | Lancet Gastroenterol Hepatol | Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. | 2020 | Details |
| A05637 | 33179890 | Am Fam Physician | Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management. | 2020 | Details |
| A05640 | 33178812 | Ann Transl Med | Diabetes and carotid artery disease: a narrative review. | 2020 | Details |
| A05646 | 33176658 | Curr Diabetes Rev | Dipeptidyl Peptidase IV Inhibitors for Nonalcoholic Fatty Liver Disease - Systematic Review and Metanalysis. | 2021 | Details |
| A05648 | 33173850 | SN Compr Clin Med | NAFLD and COVID-19: a Pooled Analysis. | 2020 | Details |
| A05649 | 33173745 | Adv Sci (Weinh) | The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36. | 2020 | Details |
| A05653 | 33171865 | Diagnostics (Basel) | Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs. | 2020 | Details |
| A05655 | 33171699 | Diagnostics (Basel) | Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study. | 2020 | Details |
| A05662 | 33169375 | Br J Pharmacol | Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. | 2020 | Details |
| A05665 | 33167521 | Int J Mol Sci | Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression. | 2020 | Details |
| A05676 | 33163950 | JHEP Rep | NAFLD and liver transplantation: Disease burden, current management and future challenges. | 2020 | Details |
| A05677 | 33163832 | Hepatol Commun | Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis. | 2020 | Details |
| A05678 | 33163831 | Hepatol Commun | Loss of Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Links Nonalcoholic Steatohepatitis to Atherosclerosis. | 2020 | Details |
| A05681 | 33161161 | Clin Gastroenterol Hepatol | Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study. | 2020 | Details |
| A05682 | 33161047 | J Hepatol | Hepatokines and adipokines in NASH-related hepatocellular carcinoma. | 2020 | Details |
| A05685 | 33159388 | FEBS Open Bio | MiR-22 modulates the expression of lipogenesis-related genes and promotes hepatic steatosis in vitro. | 2020 | Details |
| A05690 | 33156104 | Am J Gastroenterol | Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment. | 2020 | Details |
| A05692 | 33153965 | Surg Obes Relat Dis | Use of noninvasive scores for advanced liver fibrosis can guide the need for hepatic biopsy during bariatric procedures. | 2020 | Details |
| A05697 | 33152322 | Cell Metab | TANK-Binding Kinase 1 Regulates the Localization of Acyl-CoA Synthetase ACSL1 to Control Hepatic Fatty Acid Oxidation. | 2020 | Details |
| A05699 | 33150534 | Eat Weight Disord | Liver disease in obesity and underweight: the two sides of the coin. A narrative review. | 2020 | Details |
| A05712 | 33145423 | Clin Exp Hepatol | Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis - epidemiology, risk factors, clinical implications and treatment. | 2020 | Details |
| A05720 | 33143628 | Curr Diabetes Rev | Hepatic Mediators of Lipid Metabolism and Ketogenesis: Focus on Fatty Liver and Diabetes. | 2021 | Details |
| A05721 | 33143364 | Int J Mol Sci | DNA Methylation in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05726 | 33142400 | Zhonghua Yi Xue Za Zhi | [The evaluation value of transient elastography for liver characteristics in obese children]. | 2020 | Details |
| A05727 | 33142354 | Clin Transl Sci | Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05734 | 33140427 | Hepatology | Associations Between Intake of Sugar-Containing Beverages in Infancy With Liver Fat Accumulation at School Age. | 2021 | Details |
| A05739 | 33137486 | Clin Gastroenterol Hepatol | Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease. | 2020 | Details |
| A05742 | 33135718 | Food Funct | Integrative transcriptomics and metabolomics explore the mechanism of kaempferol on improving nonalcoholic steatohepatitis. | 2020 | Details |
| A05746 | 33134809 | Rheumatol Adv Pract | Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study. | 2020 | Details |
| A05747 | 33134485 | Transplant Direct | Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma. | 2020 | Details |
| A05749 | 33133304 | Dis Markers | Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. | 2020 | Details |
| A05753 | 33132631 | World J Gastroenterol | Role of betaine in liver disease-worth revisiting or has the die been cast? | 2020 | Details |
| A05769 | 33126411 | Cells | The Role of PPARs in Disease. | 2020 | Details |
| A05771 | 33126224 | Aging (Albany NY) | GDF11 induces mild hepatic fibrosis independent of metabolic health. | 2020 | Details |
| A05772 | 33125745 | Hepatology | Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. | 2021 | Details |
| A05782 | 33119748 | J Clin Endocrinol Metab | Associations of Hair Cortisol Concentrations with General and Organ Fat Measures in Childhood. | 2021 | Details |
| A05785 | 33117448 | Eur Endocrinol | The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women - A Cross-sectional Study from Southern India. | 2020 | Details |
| A05787 | 33117273 | Front Endocrinol (Lausanne) | Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice. | 2020 | Details |
| A05792 | 33115780 | Cancer Prev Res (Phila) | Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer. | 2020 | Details |
| A05794 | 33114589 | Molecules | Modulation of Lipid Metabolism by Trans-Anethole in Hepatocytes. | 2020 | Details |
| A05795 | 33114564 | Nutrients | Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation. | 2020 | Details |
| A05796 | 33114543 | J Clin Med | Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity. | 2020 | Details |
| A05799 | 33114290 | Int J Mol Sci | The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection. | 2020 | Details |
| A05801 | 33114221 | Antioxidants (Basel) | Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro. | 2020 | Details |
| A05804 | 33113993 | Nutrients | Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation. | 2020 | Details |
| A05815 | 33109219 | Lipids Health Dis | Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study. | 2020 | Details |
| A05817 | 33108553 | J Med Ultrason (2001) | Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. | 2020 | Details |
| A05826 | 33105887 | Biology (Basel) | Lauric Acid versus Palmitic Acid: Effects on Adipose Tissue Inflammation, Insulin Resistance, and Non-Alcoholic Fatty Liver Disease in Obesity. | 2020 | Details |
| A05830 | 33104787 | Phys Ther | Determinants of Physical Activity Engagement in Patients With Nonalcoholic Fatty Liver Disease: The Need for an Individualized Approach to Lifestyle Interventions. | 2021 | Details |
| A05833 | 33103450 | Am J Physiol Endocrinol Metab | Holistic characterization of single-hepatocyte transcriptome responses to high-fat diet. | 2020 | Details |
| A05835 | 33102800 | Endocrinol Diabetes Metab | Perspectives on youth-onset nonalcoholic fatty liver disease. | 2020 | Details |
| A05836 | 33102799 | Endocrinol Diabetes Metab | Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum. | 2020 | Details |
| A05837 | 33102798 | Endocrinol Diabetes Metab | Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis. | 2020 | Details |
| A05843 | 33102775 | JGH Open | Determining whether the effect of liraglutide on non-alcoholic fatty liver disease depends on reductions in the body mass index. | 2020 | Details |
| A05844 | 33102766 | JGH Open | Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non-alcoholic fatty liver disease patients. | 2020 | Details |
| A05846 | 33102749 | JGH Open | Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review. | 2020 | Details |